Physician
Patterson Schlotterer Medical Group
Patterson Schlotterer Medical Group was paid $6.41M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.
33Billing provider infoPATTERSON SCHLOTTERER MEDICAL GROUP
PHOENIX, AZ 85003
PHOENIX, AZ 85003
33aNPI1376585166assigned 06/13/2006
33bProvider typePediatrics Physician
28Total paid$6.41M
24GClaims166,284
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Arizona
Rank by total paid#14 of 235
Median peer was paid$164K
This provider vs. median39×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,858 | $860K | |
| 2019 | 25,151 | $823K | |
| 2020 | 25,088 | $777K | |
| 2021 | 27,441 | $1.04M | |
| 2022 | 26,157 | $1.11M | |
| 2023 | 23,206 | $1.00M | |
| 2024incomplete | 16,383 | $793K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 50% | 42,477 | 36,889 | $3.19M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.9% | 14,621 | 14,306 | $441K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.6% | 4,836 | 4,783 | $422K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.3% | 5,084 | 5,040 | $404K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.7% | 6,702 | 6,441 | $367K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.4% | 3,595 | 3,559 | $284K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.5% | 2,960 | 2,921 | $221K |
| 87428 | 2.7% | 2,790 | 2,731 | $175K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 5,665 | 5,509 | $80K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,734 | 1,490 | $64K |
| 90461 | <1% | 2,538 | 2,341 | $59K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 964 | 917 | $56K |
70 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,660 | $53K |
| 92551 | <1% | 7,398 | $50K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 747 | $42K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 219 | $42K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 357 | $42K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 644 | $41K |
| 81002 | <1% | 12,316 | $35K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,018 | $30K |
| 0071A | <1% | 363 | $30K | |
| 0001A | <1% | 522 | $27K | |
| 0002A | <1% | 479 | $26K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 296 | $23K |
| 99177 | <1% | 1,639 | $22K | |
| 0004A | <1% | 252 | $20K | |
| 0072A | <1% | 207 | $17K | |
| 99402 | <1% | 385 | $16K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 156 | $14K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 127 | $13K |
| 99173 | <1% | 7,323 | $13K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 558 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 303 | $11K |
| 96127 | <1% | 2,025 | $9K | |
| 0124A | <1% | 119 | $9K | |
| 94010 | <1% | 293 | $9K | |
| 99383 | <1% | 78 | $7K | |
| 99000 | <1% | 724 | $5K | |
| 99384 | <1% | 48 | $5K | |
| 0011A | <1% | 103 | $4K | |
| 90620 | <1% | 919 | $3K | |
| 0012A | <1% | 69 | $3K | |
| 94760 | <1% | 2,443 | $2K | |
| 86580 | <1% | 329 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 138 | $2K |
| 87807 | <1% | 118 | $2K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,233 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 31 | $1K |
| 95117 | <1% | 167 | $1K | |
| 90686 | <1% | 5,225 | $1K | |
| 99381 | <1% | 15 | $1K | |
| 0074A | <1% | 12 | $996.00 | |
| 96160 | <1% | 145 | $497.56 | |
| 94761 | <1% | 172 | $334.52 | |
| 90651 | <1% | 1,284 | $300.00 | |
| 90619 | <1% | 126 | $274.59 | |
| 90715 | <1% | 118 | $192.84 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 155 | $148.73 |
| 99188 | <1% | 12 | $129.91 | |
| 87070 | <1% | 440 | $114.64 | |
| 94150 | <1% | 364 | $83.49 | |
| 90672 | <1% | 354 | $28.09 | |
| 90677 | <1% | 91 | $13.89 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 157 | $6.71 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 12 | $0.61 |
| 90670 | <1% | 1,693 | $0.02 | |
| 90674 | 0% | 399 | $0.00 | |
| 3008F | 0% | 7,336 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 2,555 | $0.00 |
| 90698 | 0% | 746 | $0.00 | |
| 90744 | 0% | 269 | $0.00 | |
| 90696 | 0% | 42 | $0.00 | |
| 1220F | 0% | 349 | $0.00 | |
| 90680 | 0% | 13 | $0.00 | |
| 91301 | 0% | 29 | $0.00 | |
| 90681 | 0% | 175 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 1,124 | $0.00 |
| 90710 | 0% | 371 | $0.00 | |
| 99072 | 0% | 495 | $0.00 | |
| 90734 | 0% | 676 | $0.00 | |
| 90633 | 0% | 520 | $0.00 | |
| 90685 | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHLOTTERER, MARY (PRESIDENT)